AUSTIN, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for […]
AGREEMENTS SECURE SEVEN YEARS OF FIXED REVENUES COMBINED WITH RECENTLY ANNOUNCED 100MW/200MWH LOUISA PROJECT, ORMAT TO OWN AND OPERATE 253MW/473MWH […]